Previously: Pachyonychia congenita 4
Later onset, painful plantar keratoderma, some dystrophic nails.
siRNA (Leachman, 2010), Rapamycin (Hickerson, 2009), Statins (Zhao, 2011), EGFR inhibitors (Sprecher, 2025), Botulinum toxin (Sprecher, 2025).
Smith FJ, Jonkman MF, van Goor H et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7:1143-8.
Summarised from published literature for general information. This is not medical advice, and entries are still being verified. Read the full disclaimer
This feature is coming soon.
This is a reference resource for clinicians and researchers. It is not medical advice or a diagnostic tool.
The database is still being verified and entries may be incomplete. Do not rely on it without independent professional judgement.
If you are a patient, parent or carer, please speak to your doctor about any symptoms or concerns.